Guangdong Guanghua Sci-Tech（002741）株式概要広東光華科技有限公司は、中国で電子化学品、化学試薬、新エネルギー材料を生産・販売している。 詳細002741 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績1/6財務の健全性5/6配当金2/6報酬今年は黒字化を達成 リスク分析過去5年間で収益は年間26.8%減少しました。 財務結果に影響を与える大きな一時的項目 すべてのリスクチェックを見る002741 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCN¥Current PriceCN¥28.1327.1% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-238m4b2016201920222025202620282031Revenue CN¥3.7bEarnings CN¥131.5mAdvancedSet Fair ValueView all narrativesGuangdong Guanghua Sci-Tech Co., Ltd. 競合他社Shandong Kaisheng New MaterialsLtdSymbol: SZSE:301069Market cap: CN¥10.0bZhejiang RuntuSymbol: SZSE:002440Market cap: CN¥10.8bXinxiang Richful Lube AdditiveLtdSymbol: SZSE:300910Market cap: CN¥13.8bNorth Chemical IndustriesSymbol: SZSE:002246Market cap: CN¥12.8b価格と性能株価の高値、安値、推移の概要Guangdong Guanghua Sci-Tech過去の株価現在の株価CN¥28.1352週高値CN¥29.0852週安値CN¥14.90ベータ0.951ヶ月の変化38.98%3ヶ月変化20.83%1年変化81.13%3年間の変化70.38%5年間の変化84.70%IPOからの変化31.14%最新ニュースBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Yonghong Yan was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Mar 31+ 1 more updateGuangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Dec 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025お知らせ • Sep 04Guangdong Guanghua Sci-Tech Co., Ltd. Approves Board ElectionsGuangdong Guanghua Sci-Tech Co., Ltd. its 1st Extraordinary General Meeting of 2025 on 02 September 2025 approved the election of Yan Yonghong, independent director and Xu Tao, independent director.お知らせ • Jul 02Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025最新情報をもっと見るRecent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Yonghong Yan was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Mar 31+ 1 more updateGuangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Dec 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025お知らせ • Sep 04Guangdong Guanghua Sci-Tech Co., Ltd. Approves Board ElectionsGuangdong Guanghua Sci-Tech Co., Ltd. its 1st Extraordinary General Meeting of 2025 on 02 September 2025 approved the election of Yan Yonghong, independent director and Xu Tao, independent director.お知らせ • Jul 02Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025お知らせ • Apr 24Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 15, 2025Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: 5F, No. 295, Daxue Road, Shantou, Guangdong Chinaお知らせ • Mar 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025お知らせ • Dec 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025New Risk • Nov 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 17% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0.8% operating cash flow to total debt). Minor Risk Shareholders have been diluted in the past year (17% increase in shares outstanding).Board Change • Nov 12Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 31Third quarter 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.27 loss in 3Q 2023)Third quarter 2024 results: CN¥0.01 loss per share (improved from CN¥0.27 loss in 3Q 2023). Revenue: CN¥663.0m (down 7.5% from 3Q 2023). Net loss: CN¥3.96m (loss narrowed 96% from 3Q 2023). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.017 (vs CN¥0.069 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.017 (up from CN¥0.069 loss in 2Q 2023). Revenue: CN¥658.5m (up 7.8% from 2Q 2023). Net income: CN¥6.94m (up CN¥34.5m from 2Q 2023). Profit margin: 1.1% (up from net loss in 2Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.New Risk • Jul 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).お知らせ • Jun 29Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024New Risk • May 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change).お知らせ • Apr 29Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 17, 2024Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong Chinaお知らせ • Dec 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.062 profit in 3Q 2022)Third quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.062 profit in 3Q 2022). Revenue: CN¥733.1m (down 20% from 3Q 2022). Net loss: CN¥63.7m (down 361% from profit in 3Q 2022). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023Board Change • Sep 22Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.069 loss per share (vs CN¥0.12 profit in 2Q 2022)Second quarter 2023 results: CN¥0.069 loss per share (down from CN¥0.12 profit in 2Q 2022). Revenue: CN¥610.9m (down 39% from 2Q 2022). Net loss: CN¥27.6m (down 158% from profit in 2Q 2022). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Reported Earnings • Mar 08Full year 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.16 in FY 2021)Full year 2022 results: EPS: CN¥0.30 (up from CN¥0.16 in FY 2021). Revenue: CN¥3.30b (up 28% from FY 2021). Net income: CN¥116.9m (up 88% from FY 2021). Profit margin: 3.5% (up from 2.4% in FY 2021). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: CN¥0.062 (vs CN¥0.051 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.062 (up from CN¥0.051 in 3Q 2021). Revenue: CN¥914.5m (up 34% from 3Q 2021). Net income: CN¥24.4m (up 29% from 3Q 2021). Profit margin: 2.7% (down from 2.8% in 3Q 2021). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Zhen Feng Liang was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.049 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.12 (up from CN¥0.049 in 2Q 2021). Revenue: CN¥1.01b (up 58% from 2Q 2021). Net income: CN¥47.2m (up 142% from 2Q 2021). Profit margin: 4.7% (up from 3.1% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Yuping Wu was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 01Second quarter 2021 earnings released: EPS CN¥0.049 (vs CN¥0.064 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥635.8m (up 3.9% from 2Q 2020). Net income: CN¥19.5m (down 20% from 2Q 2020). Profit margin: 3.1% (down from 4.0% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.04 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.01b (up 18% from FY 2019). Net income: CN¥36.6m (up 171% from FY 2019). Profit margin: 1.8% (up from 0.8% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Feb 27New 90-day high: CN¥13.98The company is up 6.0% from its price of CN¥13.19 on 27 November 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Dec 16New 90-day low: CN¥12.32The company is down 17% from its price of CN¥14.81 on 18 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.Is New 90 Day High Low • Nov 27New 90-day low: CN¥12.97The company is down 6.0% from its price of CN¥13.75 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: CN¥13.21The company is down 3.0% from its price of CN¥13.55 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥706.8k, down 98% from the prior year. Total revenue was CN¥1.87b over the last 12 months, up 19% from the prior year.Is New 90 Day High Low • Oct 12New 90-day high: CN¥15.26The company is up 17% from its price of CN¥13.04 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.株主還元002741CN ChemicalsCN 市場7D21.7%0.4%-0.2%1Y81.1%61.5%36.1%株主還元を見る業界別リターン: 002741過去 1 年間で61.5 % の収益を上げたCN Chemicals業界を上回りました。リターン対市場: 002741過去 1 年間で36.1 % の収益を上げたCN市場を上回りました。価格変動Is 002741's price volatile compared to industry and market?002741 volatility002741 Average Weekly Movement8.1%Chemicals Industry Average Movement6.8%Market Average Movement6.5%10% most volatile stocks in CN Market10.1%10% least volatile stocks in CN Market4.2%安定した株価: 002741 、 CN市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 002741の 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19801,065Ren Zhengwww.ghtech.com広東広化科技有限公司は中国で電子化学品、化学試薬、新エネルギー材料を生産、販売している。硝酸銅、塩基性炭酸銅、ピロリン酸銅、酸化銅(II)、塩化銅、硫酸銅五水和物、塩基性炭酸ニッケル、酢酸ニッケル、塩化ニッケル六水和物、スルファミン酸ニッケル溶液、硫酸ニッケル六水和物、硫酸スズ、スタン酸ナトリウム三水和物、スタン酸カリウム三水和物、塩化スズ二水和物、メタンスルホン酸スズ溶液、スルファミン酸コバルト溶液、硫酸コバルト、酢酸コバルト、硝酸コバルト、塩化コバルト、ピロリン酸カリウム；およびめっき添加剤、例えばCu7およびCu6光沢剤；RSBNip10添加剤；RBNiP7光沢剤；RBNiP6、BNiP6およびJHD-201添加剤；3461D添加剤；および3471添加剤。また、硫酸ニッケル、硫酸マンガン(II)一水和物、硫酸コバルト、三元前駆体、リン酸鉄リチウム、リン酸マンガン鉄リチウム、リン酸鉄；PCB溶液；元素クラス、酸化物/過酸化物、無機酸など。有機酸、炭化水素/置換炭化水素、アルコール/フェノール/エーテル/ケトン、ニトリル/アミン/尿素などの塩；生化学試薬、クロマトグラフィー試薬、pHおよび酸化還元指示薬、光化学および電気化学分析試薬など；その他の特殊化学品。同社は、電子情報、エネルギー、自動車、医療、健康産業、インターネット、PCB、エネルギー材料、自動車部品、太陽光発電、電子部品、医薬、化学、浴室ハードウェア、研究開発、電子商取引などの業界にサービスを提供している。製品は東南アジア、ヨーロッパ、アメリカなど世界各国に輸出している。前身は汕頭光華化工有限公司で、2010年に広東光華科技有限公司に社名を変更した。1980年に設立され、中国汕頭市に本社を置く。もっと見るGuangdong Guanghua Sci-Tech Co., Ltd. 基礎のまとめGuangdong Guanghua Sci-Tech の収益と売上を時価総額と比較するとどうか。002741 基礎統計学時価総額CN¥13.08b収益（TTM）CN¥119.84m売上高(TTM)CN¥3.35b109.2xPER（株価収益率3.9xP/Sレシオ002741 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計002741 損益計算書（TTM）収益CN¥3.35b売上原価CN¥2.81b売上総利益CN¥532.30mその他の費用CN¥412.47m収益CN¥119.84m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.26グロス・マージン15.91%純利益率3.58%有利子負債／自己資本比率47.9%002741 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.4%現在の配当利回り39%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 14:42終値2026/05/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Guangdong Guanghua Sci-Tech Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Wang ZheCitic Securities Co., Ltd.Zhe WangCitic Securities Co., Ltd.Qi ZhouHaitong International Research Limited1 その他のアナリストを表示
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Yonghong Yan was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 31+ 1 more updateGuangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Dec 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025
お知らせ • Sep 04Guangdong Guanghua Sci-Tech Co., Ltd. Approves Board ElectionsGuangdong Guanghua Sci-Tech Co., Ltd. its 1st Extraordinary General Meeting of 2025 on 02 September 2025 approved the election of Yan Yonghong, independent director and Xu Tao, independent director.
お知らせ • Jul 02Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Yonghong Yan was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 31+ 1 more updateGuangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Dec 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025
お知らせ • Sep 04Guangdong Guanghua Sci-Tech Co., Ltd. Approves Board ElectionsGuangdong Guanghua Sci-Tech Co., Ltd. its 1st Extraordinary General Meeting of 2025 on 02 September 2025 approved the election of Yan Yonghong, independent director and Xu Tao, independent director.
お知らせ • Jul 02Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025
お知らせ • Apr 24Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 15, 2025Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: 5F, No. 295, Daxue Road, Shantou, Guangdong China
お知らせ • Mar 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025
お知らせ • Dec 31Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025
New Risk • Nov 16New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 17% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0.8% operating cash flow to total debt). Minor Risk Shareholders have been diluted in the past year (17% increase in shares outstanding).
Board Change • Nov 12Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 31Third quarter 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.27 loss in 3Q 2023)Third quarter 2024 results: CN¥0.01 loss per share (improved from CN¥0.27 loss in 3Q 2023). Revenue: CN¥663.0m (down 7.5% from 3Q 2023). Net loss: CN¥3.96m (loss narrowed 96% from 3Q 2023). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.017 (vs CN¥0.069 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.017 (up from CN¥0.069 loss in 2Q 2023). Revenue: CN¥658.5m (up 7.8% from 2Q 2023). Net income: CN¥6.94m (up CN¥34.5m from 2Q 2023). Profit margin: 1.1% (up from net loss in 2Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
New Risk • Jul 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).
お知らせ • Jun 29Guangdong Guanghua Sci-Tech Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024
New Risk • May 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change).
お知らせ • Apr 29Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 17, 2024Guangdong Guanghua Sci-Tech Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong China
お知らせ • Dec 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.062 profit in 3Q 2022)Third quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.062 profit in 3Q 2022). Revenue: CN¥733.1m (down 20% from 3Q 2022). Net loss: CN¥63.7m (down 361% from profit in 3Q 2022). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 30Guangdong Guanghua Sci-Tech Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023Guangdong Guanghua Sci-Tech Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023
Board Change • Sep 22Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 31Second quarter 2023 earnings released: CN¥0.069 loss per share (vs CN¥0.12 profit in 2Q 2022)Second quarter 2023 results: CN¥0.069 loss per share (down from CN¥0.12 profit in 2Q 2022). Revenue: CN¥610.9m (down 39% from 2Q 2022). Net loss: CN¥27.6m (down 158% from profit in 2Q 2022). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 08Full year 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.16 in FY 2021)Full year 2022 results: EPS: CN¥0.30 (up from CN¥0.16 in FY 2021). Revenue: CN¥3.30b (up 28% from FY 2021). Net income: CN¥116.9m (up 88% from FY 2021). Profit margin: 3.5% (up from 2.4% in FY 2021). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Zhen Feng Liang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: CN¥0.062 (vs CN¥0.051 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.062 (up from CN¥0.051 in 3Q 2021). Revenue: CN¥914.5m (up 34% from 3Q 2021). Net income: CN¥24.4m (up 29% from 3Q 2021). Profit margin: 2.7% (down from 2.8% in 3Q 2021). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Zhen Feng Liang was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.049 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.12 (up from CN¥0.049 in 2Q 2021). Revenue: CN¥1.01b (up 58% from 2Q 2021). Net income: CN¥47.2m (up 142% from 2Q 2021). Profit margin: 4.7% (up from 3.1% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Yuping Wu was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 01Second quarter 2021 earnings released: EPS CN¥0.049 (vs CN¥0.064 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥635.8m (up 3.9% from 2Q 2020). Net income: CN¥19.5m (down 20% from 2Q 2020). Profit margin: 3.1% (down from 4.0% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.04 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.01b (up 18% from FY 2019). Net income: CN¥36.6m (up 171% from FY 2019). Profit margin: 1.8% (up from 0.8% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Feb 27New 90-day high: CN¥13.98The company is up 6.0% from its price of CN¥13.19 on 27 November 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Dec 16New 90-day low: CN¥12.32The company is down 17% from its price of CN¥14.81 on 18 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Nov 27New 90-day low: CN¥12.97The company is down 6.0% from its price of CN¥13.75 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥13.21The company is down 3.0% from its price of CN¥13.55 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥706.8k, down 98% from the prior year. Total revenue was CN¥1.87b over the last 12 months, up 19% from the prior year.
Is New 90 Day High Low • Oct 12New 90-day high: CN¥15.26The company is up 17% from its price of CN¥13.04 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.
